"The
Report Solid Tumors Market in Asia Pacific to 2019 - New Drug
Approvals and Anticipated Product Launches to Trigger a Shift in
Treatment Paradigm to Targeted Therapies provides information on
pricing, market analysis, shares, forecast, and company profiles for
key industry participants. - MarketResearchReports.biz"
GBI
Research, the leading business intelligence provider, has released
its latest research: Solid Tumors in Asia-Pacific Market to 2019 -
New and Anticipated Approvals of Targeted Therapies to Trigger a
Shift in Treatment Paradigm, which provides in-depth analysis of four
key therapeutic indications within the Asia-Pacific (APAC) solid
tumors market – bladder cancer, ovarian cancer, pancreatic cancer
and prostate cancer – covering the four countries of Australia,
China, India and Japan. The report provides an estimation of market
size for 2012, along with market forecast until 2019. It also covers
disease epidemiology, treatment algorithms, treatment patterns,
in-depth analysis of the pipeline, and deal analysis for these four
solid tumor types.
The
value of the solid tumors market in the APAC region amounted to an
estimated $1 billion in 2012 and is expected to register a modest
Compound Annual Growth Rate (CAGR) of 12.3% to reach $2.3 billion in
2019. The key drivers for growth in this market include: new product
approvals in ovarian, pancreatic and prostate cancers; expected
launches from the promising ovarian and prostate cancer pipelines;
and increased market penetration due to the anticipated
implementation of social insurance in China. Conversely, the growth
of the market in this region could face some restricting influences,
including: the recent implementation of a price ceiling on essential
drugs in India; anticipated pricing restrictions in China; low access
and penetration; and price erosion due to generic competition.
Scope
The
report analyzes treatment usage patterns, market characterization,
pipeline analysis and key licensing and co-development deals in the
bladde
View Report At
http://www.marketresearchreports.biz/analysis/175327
The report includes:
- Disease overview, as well as treatment algorithms and treatment usage patterns
- Market size and forecast for the APAC solid tumors market from 2012 to 2019
- Major marketed products in the APAC region for all four solid tumor types covered
- In-depth pipeline analysis for all four solid tumor types
- Key drivers and restraints that have had and are expected to have a significant impact upon the market
- Key licensing and co-development agreements in the solid tumors market
Reasons to Buy
The report will enhance your
decision-making capability by allowing you to:
- Align your product portfolio to the markets with high growth potential
- Develop market entry and expansion strategies by identifying the potential regions and therapeutic segments poised for strong growth
- Devise a more effectively tailored country strategy through the understanding of key drivers and barriers in the solid tumors market
- Develop key strategic initiatives based upon an understanding of key focus areas and leading companies
- Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships
Download
Sample copy of this Report at :
http://www.marketresearchreports.biz/sample/sample/175327
Table
of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Solid Tumors Market in Asia
Pacific to 2019 - Introduction
2.1 Introduction
3 Solid Tumors Market in Asia
Pacific to 2019 - Therapeutic Landscape
3.1 Bladder Cancer
3.1.1 Symptoms
3.1.2 Etiology
3.1.3 Pathophysiology
3.1.4 Diagnosis
3.1.5 Classification
3.1.6 Epidemiology
3.1.7 Prognosis and Disease
Staging
3.1.8 Treatment Options
3.2 Ovarian Cancer
3.2.1 Symptoms
3.2.2 Etiology
3.2.3 Pathophysiology
3.2.4 Diagnosis
3.2.5 Classification
3.2.6 Epidemiology
3.2.7 Prognosis and Disease
Staging
3.2.8 Treatment Options
3.3 Pancreatic Cancer
3.3.1 Symptoms
3.3.2 Etiology
3.3.3 Pathophysiology
3.3.4 Diagnosis
3.3.5 Classification
3.3.6 Epidemiology
3.3.7 Prognosis and Disease
Staging
3.3.8 Treatment Algorithm
3.4 Prostate Cancer
3.4.1 Symptoms
3.4.2 Etiology
3.4.3 Pathophysiology
3.4.4 Co-Morbidities and
Complications
3.4.5 Diagnosis
3.4.6 Classification
3.4.7 Epidemiology
3.4.8 Prognosis and Disease
Staging
3.4.9 Treatment Options
4 Solid Tumors Market in Asia
Pacific to 2019 - Marketed Products
4.1 Bladder Cancer
4.2 Ovarian Cancer
4.3 Pancreatic Cancer
4.4 Prostate Cancer
4.5 Key Marketed Products
4.5.1 Carboplatin
4.5.2 Cisplatin
4.5.3 Gemcitabine
4.5.4 Paclitaxel
4.5.5 Doxorubicin
4.5.6 Avastin (bevacizumab)
4.5.7 Tarceva (erlotinib)
4.5.8 Sutent (sunitinib)
4.5.9 Afinitor (everolimus)
4.5.10 Taxotere (docetaxel)
4.5.11 Zytiga (abiraterone
acetate)
4.5.12 Jevtana (cabazitaxel)
5 Solid Tumors Market in Asia
Pacific to 2019 - Pipeline Analysis
5.1 Bladder Cancer Pipeline
5.1.1 Overall Pipeline
5.1.2 Pipeline Analysis by
Molecule Type
5.1.3 Pipeline Analysis by
Mechanism of Action
5.2 Ovarian Cancer Pipeline
5.2.1 Overall Pipeline
5.2.2 Pipeline Analysis by
Molecule Type
5.2.3 Pipeline Analysis by
Mechanism of Action
5.3 Pancreatic Cancer Pipeline
5.3.1 Overall Pipeline
5.3.2 Pipeline Analysis by
Molecule Type
5.3.3 Pipeline Analysis by
Mechanism of Action
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment